HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 357 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,077 | -99.9% | 18,928 | -18.1% | 0.03% | +8.0% |
| Q3 2022 | $914,000 | -12.6% | 23,122 | -2.8% | 0.02% | -7.4% |
| Q2 2022 | $1,046,000 | -1.1% | 23,776 | -10.4% | 0.03% | +12.5% |
| Q1 2022 | $1,058,000 | +19.1% | 26,526 | +20.2% | 0.02% | +26.3% |
| Q4 2021 | $888,000 | +7.5% | 22,076 | +8.7% | 0.02% | 0.0% |
| Q3 2021 | $826,000 | -10.2% | 20,316 | +0.2% | 0.02% | -13.6% |
| Q2 2021 | $920,000 | +8.7% | 20,270 | -0.1% | 0.02% | +4.8% |
| Q1 2021 | $846,000 | -0.8% | 20,300 | +1.7% | 0.02% | -4.5% |
| Q4 2020 | $853,000 | – | 19,970 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 7,048,282 | $126,799,000 | 27.23% |
| First Light Asset Management, LLC | 1,630,591 | $29,334,000 | 5.01% |
| SNYDER CAPITAL MANAGEMENT L P | 3,393,057 | $61,041,000 | 3.48% |
| Bellevue Group AG | 7,663,956 | $137,874,000 | 2.67% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 307,633 | $5,531,000 | 2.52% |
| Lombard Odier Asset Management (Switzerland) SA | 900,000 | $16,191,000 | 2.17% |
| Elk Creek Partners, LLC | 654,362 | $11,772,000 | 2.02% |
| DOHENY ASSET MANAGEMENT /CA | 127,110 | $2,254,000 | 1.79% |
| Granite Investment Partners, LLC | 1,277,438 | $22,981,000 | 1.49% |
| Amia Capital LLP | 69,409 | $1,249,000 | 1.11% |